Cargando…

Intraoperative Anaphylaxis in Response to Hemostatic Agents With Protein Derivatives

Topical hemostatic agents are commonly used in a wide variety of surgical procedures to assist in hemostasis. However, the use of these agents is not without risk as many contain biologically active agents derived from human and animal products that have the potential to cause adverse reactions. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Holbert, S. Elliott, Patel, Darren, Rizk, Tony, Dimitri, Nahu G, Jones, Micah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500731/
https://www.ncbi.nlm.nih.gov/pubmed/32963920
http://dx.doi.org/10.7759/cureus.9881
_version_ 1783583913658023936
author Holbert, S. Elliott
Patel, Darren
Rizk, Tony
Dimitri, Nahu G
Jones, Micah
author_facet Holbert, S. Elliott
Patel, Darren
Rizk, Tony
Dimitri, Nahu G
Jones, Micah
author_sort Holbert, S. Elliott
collection PubMed
description Topical hemostatic agents are commonly used in a wide variety of surgical procedures to assist in hemostasis. However, the use of these agents is not without risk as many contain biologically active agents derived from human and animal products that have the potential to cause adverse reactions. This case report covers a 44-year-old man with a history of alpha-gal syndrome who was scheduled for an open reduction and internal fixation of a left distal radius fracture. Alpha-gal syndrome is characterized by an IgE-mediated type 1 hypersensitivity reaction to a mammalian oligosaccharide epitope. Patients with this condition have a history of a past tick bite and subsequent development of an allergic reaction to mammalian protein products, most notably red meat. The patient had concerns about products used during surgery and potential reactions based on his allergy. The intent of this case report is to promote physician awareness of the widespread use of mammalian products in surgical hemostatic agents and potential immunogenic reactions. By increasing awareness of the alpha-gal syndrome, the goal is that medical device companies will actively disclose product components that could potentiate these adverse reactions and continue to develop alternative agents.
format Online
Article
Text
id pubmed-7500731
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-75007312020-09-21 Intraoperative Anaphylaxis in Response to Hemostatic Agents With Protein Derivatives Holbert, S. Elliott Patel, Darren Rizk, Tony Dimitri, Nahu G Jones, Micah Cureus Allergy/Immunology Topical hemostatic agents are commonly used in a wide variety of surgical procedures to assist in hemostasis. However, the use of these agents is not without risk as many contain biologically active agents derived from human and animal products that have the potential to cause adverse reactions. This case report covers a 44-year-old man with a history of alpha-gal syndrome who was scheduled for an open reduction and internal fixation of a left distal radius fracture. Alpha-gal syndrome is characterized by an IgE-mediated type 1 hypersensitivity reaction to a mammalian oligosaccharide epitope. Patients with this condition have a history of a past tick bite and subsequent development of an allergic reaction to mammalian protein products, most notably red meat. The patient had concerns about products used during surgery and potential reactions based on his allergy. The intent of this case report is to promote physician awareness of the widespread use of mammalian products in surgical hemostatic agents and potential immunogenic reactions. By increasing awareness of the alpha-gal syndrome, the goal is that medical device companies will actively disclose product components that could potentiate these adverse reactions and continue to develop alternative agents. Cureus 2020-08-19 /pmc/articles/PMC7500731/ /pubmed/32963920 http://dx.doi.org/10.7759/cureus.9881 Text en Copyright © 2020, Holbert et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Allergy/Immunology
Holbert, S. Elliott
Patel, Darren
Rizk, Tony
Dimitri, Nahu G
Jones, Micah
Intraoperative Anaphylaxis in Response to Hemostatic Agents With Protein Derivatives
title Intraoperative Anaphylaxis in Response to Hemostatic Agents With Protein Derivatives
title_full Intraoperative Anaphylaxis in Response to Hemostatic Agents With Protein Derivatives
title_fullStr Intraoperative Anaphylaxis in Response to Hemostatic Agents With Protein Derivatives
title_full_unstemmed Intraoperative Anaphylaxis in Response to Hemostatic Agents With Protein Derivatives
title_short Intraoperative Anaphylaxis in Response to Hemostatic Agents With Protein Derivatives
title_sort intraoperative anaphylaxis in response to hemostatic agents with protein derivatives
topic Allergy/Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500731/
https://www.ncbi.nlm.nih.gov/pubmed/32963920
http://dx.doi.org/10.7759/cureus.9881
work_keys_str_mv AT holbertselliott intraoperativeanaphylaxisinresponsetohemostaticagentswithproteinderivatives
AT pateldarren intraoperativeanaphylaxisinresponsetohemostaticagentswithproteinderivatives
AT rizktony intraoperativeanaphylaxisinresponsetohemostaticagentswithproteinderivatives
AT dimitrinahug intraoperativeanaphylaxisinresponsetohemostaticagentswithproteinderivatives
AT jonesmicah intraoperativeanaphylaxisinresponsetohemostaticagentswithproteinderivatives